Clinical trial
A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing…
NCT00289029 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00289029 |
|---|---|
| Title | A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography |
| Official title | Visipaque and Isovue in Cardiac Angiography in Renally Impaired Patients |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | CIN |
| Intervention type | Drug |
| Interventions | Iopamidol 370 mgI/mL |
| Enrollment | 400 |
| Start date | Jul 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Feb 9, 2006 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: